These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Renal protective effects of specific cyclooxygenase-2 inhibitor in rats with subtotal renal ablation]. Kong WX; Ma J; Gu Y; Yang HC; Zuo YQ; Lin SY Zhonghua Nei Ke Za Zhi; 2003 Mar; 42(3):186-90. PubMed ID: 12816702 [TBL] [Abstract][Full Text] [Related]
7. Effects of cyclooxygenase-2 (COX-2) inhibition on plasma and renal renin in diabetes. Komers R; Tian W; Lindsley JN; Oyama TT; Cohen DM; Anderson S J Lab Clin Med; 2002 Nov; 140(5):351-7. PubMed ID: 12434137 [TBL] [Abstract][Full Text] [Related]
8. Interactions of the renin-angiotensin system and neuronal nitric oxide synthase in regulation of cyclooxygenase-2 in the macula densa. Harris RC; Cheng H; Wang J; Zhang M; McKanna JA Acta Physiol Scand; 2000 Jan; 168(1):47-51. PubMed ID: 10691779 [TBL] [Abstract][Full Text] [Related]
10. Expression of mediators of renal injury in the remnant kidney of ROP mice is attenuated by cyclooxygenase-2 inhibition. Cheng H; Zhang M; Moeckel GW; Zhao Y; Wang S; Qi Z; Breyer MD; Harris RC Nephron Exp Nephrol; 2005; 101(3):e75-85. PubMed ID: 15995341 [TBL] [Abstract][Full Text] [Related]
11. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure]. Ciechanowicz A Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103 [TBL] [Abstract][Full Text] [Related]
12. Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy. Benigni A; Zoja C; Zatelli C; Corna D; Longaretti L; Rottoli D; Maggioni P; Todeschini M; Noris M; Remuzzi G Kidney Int; 2004 Nov; 66(5):1959-65. PubMed ID: 15496167 [TBL] [Abstract][Full Text] [Related]
15. A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells. Liu H; Peng Y; Liu F; Li J; Chen X; Liu Y; Zhang H Cell Biol Int; 2007 May; 31(5):508-15. PubMed ID: 17196403 [TBL] [Abstract][Full Text] [Related]
16. Prostaglandins that increase renin production in response to ACE inhibition are not derived from cyclooxygenase-1. Cheng HF; Wang SW; Zhang MZ; McKanna JA; Breyer R; Harris RC Am J Physiol Regul Integr Comp Physiol; 2002 Sep; 283(3):R638-46. PubMed ID: 12184998 [TBL] [Abstract][Full Text] [Related]
17. Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension. Hermann M; Shaw S; Kiss E; Camici G; Bühler N; Chenevard R; Lüscher TF; Gröne HJ; Ruschitzka F Hypertension; 2005 Feb; 45(2):193-7. PubMed ID: 15630049 [TBL] [Abstract][Full Text] [Related]
18. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat. Szabo A; Lutz J; Schleimer K; Antus B; Hamar P; Philipp T; Heemann U Kidney Int; 2000 Mar; 57(3):982-91. PubMed ID: 10720951 [TBL] [Abstract][Full Text] [Related]
19. Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation. Kanazawa M; Kawamura T; Li L; Sasaki Y; Matsumoto K; Kataoka H; Ito O; Minami N; Sato T; Ootaka T; Kohzuki M Am J Hypertens; 2006 Jan; 19(1):80-6. PubMed ID: 16461196 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. Anderson S; Rennke HG; Brenner BM J Clin Invest; 1986 Jun; 77(6):1993-2000. PubMed ID: 3011863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]